BioSpace News Archive

Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases

March 7, 2023
·
7 min read
Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients

Restore Medical Ltd, a privately held medical device company, has successfully completed enrollment of the First In Human clinical study with its CONTRABAND™ device.

March 7, 2023
·
1 min read
Business

Alpha-9 Theranostics Strengthens its Scientific Expertise with Key Appointments to Leadership Team and Scientific Advisory Board

Alpha-9 Theranostics, a clinical stage biotechnology company developing differentiated and highly targeted radiopharmaceuticals, announced the appointment of Jutta Wanner, Ph.D. as Senior Vice President of Drug Discovery.

March 7, 2023
·
3 min read
Business

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

908 Devices Inc., a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, reported financial results for the quarter and full year ended December 31, 2022.

March 7, 2023
·
8 min read
Business

Seres Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported fourth quarter and full year 2022 financial results and provided business updates.

March 7, 2023
·
14 min read
Genetown

Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed

Flagship Pioneering, the bioplatform innovation company, unveiled Ampersand Biomedicines, a company creating programmable medicines that are safer, more tolerable, and effective by acting at the site of disease.

March 7, 2023
·
4 min read
BioMidwest

Delphinus Medical Announces Installation of SoftVue Breast Imaging System at UR Medicine

Delphinus Medical Technologies announced today the latest installation of its SoftVue™ 3D Whole Breast Ultrasound Tomography System since FDA approval of its advanced technology for screening women with dense breast tissue.

March 7, 2023
·
3 min read
Business

ElevateBio Appoints Heidi L. Wagner, J.D., as Global Head of Government Affairs

ElevateBio, LLC today announced that Heidi L. Wagner, J.D., will be joining as Global Head of Government Affairs.

March 7, 2023
·
4 min read
Business

Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer

Capsida Biotherapeutics Inc. (“Capsida”) today announced the appointment of Susan Catalano, Ph.D., as the company’s Chief Scientific Officer (CSO).

March 7, 2023
·
4 min read
Genetown

ProQR to Present at Upcoming March 2023 Scientific and Industry Conferences

ProQR Therapeutics N.V. announced several presentations highlighting the Company’s proprietary Axiomer® RNA editing technology platform at upcoming scientific and industry conferences.

March 7, 2023
·
6 min read